Literature DB >> 26376655

Accuracy of Tokuhashi score system in predicting survival of lung cancer patients with vertebral metastasis.

Wenxi Yu1, Lina Tang1, Feng Lin1, Yang Yao1, Zan Shen2.   

Abstract

Controversy exists in the accuracy of Tokuhashi score (TS) system in predicting survival of patients with vertebral metastasis, including vertebral metastases from primary lung cancer. To calculate the accuracy of the TS in predicting survival of lung cancer patients with vertebral metastasis and investigate which subgroup's survival is suitable for TS to predict, we conduct this retrospective study. From January 2008 to December 2013, 151 patients with vertebral metastases from primary lung cancer in our institute were included. The data were censored at December 2014. Patients were classified according to TS. The actual and predicted survivals were compared to calculate the accuracy rate. Spearman's correlation analysis was conducted to explore the relation between overall survival and TS. Cox regression was carried out to investigate potential factors affecting prognosis. Only 8.6 % (13 patients) actually followed the survivorship pattern as predicted by the TS. Spearman's correlation analysis demonstrated that actual overall survival correlated significantly with the TS. Cox model indicated that status of visceral metastases (i.e., none, involved with lung, involved with extrapulmonary organ) and response to first-time systemic therapy (effective or not) are associated significantly with overall survival. For patients with visceral metastases and progression to first-time systemic therapy simultaneously, predicted survival by TS and actual survival matched well. TS could only predict survival accurately in those with visceral metastases and disease progression to first-time systemic therapy simultaneously. Thus, it may not be a reliable tool to predict survival in lung cancer patients with vertebral metastasis. Status of visceral metastases and response to first-time systemic therapy should be added into TS system to increase validity and accuracy.

Entities:  

Keywords:  Lung cancer; Survival; Tokuhashi score; Vertebral metastasis

Mesh:

Year:  2015        PMID: 26376655     DOI: 10.1007/s11060-015-1934-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  39 in total

Review 1.  First-line chemotherapy in metastatic small-cell lung cancer (SCLC).

Authors:  Martin Wolf; Sandra Tebbe; Thomas Fink
Journal:  Lung Cancer       Date:  2004-08       Impact factor: 5.705

Review 2.  Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group.

Authors:  David Choi; A Crockard; C Bunger; J Harms; N Kawahara; C Mazel; R Melcher; K Tomita
Journal:  Eur Spine J       Date:  2009-12-29       Impact factor: 3.134

3.  A comparison of the modified Tokuhashi and Tomita scores in determining prognosis for patients afflicted with spinal metastasis.

Authors:  Ahmed Aoude; Louis-Philippe Amiot
Journal:  Can J Surg       Date:  2014-06       Impact factor: 2.089

4.  Metastases to the vertebral column.

Authors:  V L Fornasier; J G Horne
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

5.  Survival prognostic factors and clinical outcomes in patients with spinal metastases.

Authors:  Vincent Pointillart; Jean-Marc Vital; Rachid Salmi; Abou Diallo; Gerald M Quan
Journal:  J Cancer Res Clin Oncol       Date:  2010-09-04       Impact factor: 4.553

6.  Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis.

Authors:  Hyun-Mi Bae; Se-Hoon Lee; Tae Min Kim; Dong-Wan Kim; Seok-Chul Yang; Hong Gyun Wu; Young Whan Kim; Dae Seog Heo
Journal:  Lung Cancer       Date:  2012-06-04       Impact factor: 5.705

7.  Survival, complications and outcome in 282 patients operated for neurological deficit due to thoracic or lumbar spinal metastases.

Authors:  Karl-Ake Jansson; Henrik C F Bauer
Journal:  Eur Spine J       Date:  2005-03-03       Impact factor: 3.134

8.  [Surgical management of vertebral column metastatic disease].

Authors:  K-D Schaser; I Melcher; T Mittlmeier; A Schulz; J H Seemann; N P Haas; A C Disch
Journal:  Unfallchirurg       Date:  2007-02       Impact factor: 1.000

Review 9.  Review of the current targeted therapies for non-small-cell lung cancer.

Authors:  Kim-Son H Nguyen; Joel W Neal; Heather Wakelee
Journal:  World J Clin Oncol       Date:  2014-10-10

10.  Analysis of the predictive role and new proposal for surgical strategies based on the modified Tomita and Tokuhashi scoring systems for spinal metastasis.

Authors:  Junhyung Kim; Sun-Ho Lee; Se-Jun Park; Sung-Soo Chung; Eun-Sang Kim; Whan Eoh; Chong-Suh Lee
Journal:  World J Surg Oncol       Date:  2014-08-01       Impact factor: 2.754

View more
  2 in total

1.  The revised Tokuhashi score; analysis of parameters and assessment of its accuracy in determining survival in patients afflicted with spinal metastasis.

Authors:  A Aoude; M Fortin; Sulta Aldebeyan; J Ouellet; L P Amiot; M H Weber; P Jarzem
Journal:  Eur Spine J       Date:  2016-12-23       Impact factor: 3.134

2.  Decision support systems for incurable non-small cell lung cancer: a systematic review.

Authors:  D Révész; E G Engelhardt; J J Tamminga; F M N H Schramel; B D Onwuteaka-Philipsen; E M W van de Garde; E W Steyerberg; E P Jansma; H C W De Vet; V M H Coupé
Journal:  BMC Med Inform Decis Mak       Date:  2017-10-02       Impact factor: 2.796

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.